Autoantibodies against cerebral gray matter in patients with insulin dependant diabetes mellitus by Stöcker, W. et al.
Immunobiology 
Zeitschrift für Immunitätsforschung 
Editors 
E. D . A L B E R T , München • D . BlTTER-SUERMANN, Hannover • M . P. D l E R l C H , Innsbruck • 
M . F E L D M A N N , London • S. H . E . K A U F M A N N , U l m • E . K L E I N , Stockholm • W. K Ö H L E R , 
Jena • U . K O S Z I N O W S K I , U l m • P. K R A M M E R , Heidelberg • M . LOOS, Mainz • T. LUGER, 
Münster • L . J. O L D , New York • J. J. OPPENHEIM, Frederick • H . H . PETER, Freiburg • 
K . PF1ZENMAIER, Göttingen • M . R Ö L L I N G H O F F , Erlangen • D . SCHENDEL, München • 
V. SCHIRRMACHER , Heidelberg • C. SORG, Münster • R. VAN FURTH, Leiden • H . WAGNER, 
München • H . WEKERLE, Martinsried • G. W l C K , Innsbruck • R. ZlNKERNAGEL, Zürich 
Editor-in-Chief 
D . GEMSA, Marburg 
Editorial Advisory Board 
R. AVERDUNK, Berlin • J. F . B A C H , Paris • H . B A L N E R , Rijswijk • R. BENNER, Rotterdam • 
H . v. B O E H M E R , Basel • G. B O N N A R D , Bern • D . G. B R A U N , Basel • V. B R A U N , Tübingen • 
J . BROSTOFF , London • A. C O U T I N H O , Paris • T . D I A M A N T S T E I N , Berlin • W . D R Ö G E , 
Heidelberg • P. D U K O R , Basel • P. ERB , Basel • H . - D . F L A D , Borstel • O . G Ö T Z E , Göttingen • 
E. G Ü N T H E R , Göttingen • U . H A D D I N G , Mainz • H . H A H N , Berlin • K. H Ä L A , Innsbruck • 
G . J. H A M M ERLING, Heidelberg • K. U . H A R T M A N N , Marburg • H . ZUR H A U S E N , Heidelberg • 
M . HESS, Bern • J. K A L D E N , Erlangen • T . J. K I N D T , New York • E . K O W N A T Z K I , Freiburg • 
W . LEIßOLD, Hannover • K. LENNERT, Kiel • F. LILLY, New York • J. L I N D E M A N N , Zürich • 
E. MACHER, Münster • H . METZGER, Bethesda • V. TER M E U L E N , Würzburg • H . J. M Ü L L E R -
E B E R H A R D , Hamburg • W . M Ü L L E R - R U C H H O L T Z , Kiel • H . PETERS, Göttingen • E . PlCK, Tel 
Aviv • O . PROKOP, Berlin • M . QUASTEL, Beer Sheva • J. P. R E V I L L A R D , Lyon • E . P. RlEBER, 
München • E. R Ü D E , Mainz • E . SCHÖPF, Freiburg • H . G. SCHWICK, Marburg • K. SETHI, 
Heidelberg • G. SUNSHINE, London • N . T A L A L , San Francisco • G. T I L L , Ann Arbor • 








Active ulcerative colitis, p - A N C A . . . . 
Adenylate cyclase, regulation 
Alveolar leukocytes, hyporesponsive-
ness 
Alveolar leukocytes, interferon inducers . 
Anti-self reactivity, M H C class I genes . 
Antibody-forming cells, intestinal 
antigen 
A u t o - M H C Class II-reactive T cell line . 
Autoimmune thyroiditis 
BCG-immunized mice, interferon-y pro-
duction 
Borrelia burgdorferi associated antigens, 
monoclonal antibodies 
C D 4 + lymphocyte dynamics, H I V 
infected individuals 
C D 8 + cells, hemorrhaged mice 
Chondrocytes, Mycoplasma arthritidis . 
Colony stimulating activity, Hodgkin's 
disease 
Crohn's disease, p - A N C A 
Cyclophosphamide-induced tolerance . . 
Cyclosporins A , granulocyte function . . 
Dendritic cell-associated molecule . . . . 
Dendritic cells, H L A class I I molecules . 
Endothelial cells, tumor necrosis 
factor-a 
Endotoxin administration, neopterin 
levels 
Exocytosis, nucleotide-induced 
Granulocyte function, cyclosporine A . . 
Granulocytes and endothelial cells, 
tumor necrosis factor-a 
Granulocytes, monoclonal antibody . . . 
Hemorrhaged mice, transfer of T cells . . 
Hepatitis virus type 3, age-dependent 
resistance 
Hepatitis virus type 3, macrophage 
activation 
H I V infected individuals, C D 4 + 
dynamics 
H I V infected individuals, C D 4 + 
276 dynamics 108 
406 H L A class I I molecules, dendritic cells . . 335 
51 H L A class I I molecules, monocytes . . . 335 
H L A - B 8 , D R positive individuals, 
84 T lymphocyte activation 257 
84 Hodgkin's disease, colony stimulating 
438 activity 288 
Hybridoma suppressor factor (HSF) . . . 64 
97 
3 6 7 I L - 1 receptor 13 
4 1 4 IL-2 receptor 13 
IL-2 , suppressor cells 345 
Indomethacin, suppressor cells 345 
40 Inhibit ion of proliferation, TGF-ß . . . . 13 
Interferon production, leukotriene C 4 . . 40 
357 Interferon-a inducers, alveolar 
leukocytes 84 
Interferon-y inducers, alveolar 
leukocytes 84 
Intestinal antigen, antibody-forming 
3 9 8 cells 97 
288 Leukotriene C 4 , interferon production . . 40 
406 L p r - G V H D , characterization 367 
430 Lymphokine production, hybridoma 
22 suppressor factor (HSF) 64 
Macrophage activation, hepatitis virus 
335 3 1 
Macrophage activation, interferon-y . . . 31 
Macrophages, tumor-associated 276 
M H C class I genes, anti-self reactivity . . 438 
267 Model-based analysis, H I V infected 
individuals 108 
3 1 7 Monoclonal antibodies, Borrelia 
298 burgdorferi associated antigens . . . . 357 
Monoclonal antibody, rat granulocytes . 324 
22 Monocytes, H L A class I I molecules . . . 335 
Monocytes, Hodgkin's disease 288 
267 MRL/+mice 367 
324 Mycoplasma arthritidis, T cell lines . . . 398 
379 Neopterin levels, endotoxin administra-
tion 317 
31 Neutrophils, k i l l of tumor cells 1 
Neutrophils, tumoricidal factor 1 
31 NLDC-145 molecule, dendritic 
cell-associated 388 
108 N o n - H - 2 alloantigen 430 
460 • Subject Index 
p - A N C A , ulcerative colitis 
Peyer's patches inactivation 
Peyer's patches, antibody-forming cells . 
Spontaneous autoimmune thyroiditis . . 
Staphylococcal enterotoxin A , inter-
f e r o n ^ production 
Suppressor cells, effect of IL-2 
Suppressor cells, effect of indomethacin . 
ß2-adrenoceptors, regulation 
f cell line, l p r - G V H D 
406 T cell lines, Mycoplasma arthriddis . . . 398 
97 T lymphocyte markers, H L A - B 8 , DR3 
97 positive individuals 257 
Tolerance, non-H-2-alIoantigen 430 
^ Transfer of T cells, hemorrhaged mice . . 379 
Transforming growth factor-beta . . . . 13 
^ Tumor cells, killed by neutrophils . . . . 1 
Tumor necrosis factor-a, granulocytes 
and endothelial cells 267 
Tumor-associated macrophages 276 
51 Ultrastructural study, granulocytes and 
367 endothelial cells 267 
XXIs t Meeting of the Society of Immunology • 223 
'Departments of 'Medicine and 2 Neurology, Medical University of Lübeck, and 3 E U R O I M -
M U N , Lübeck, FRG 
J.14 Autoantibodies against cerebral gray matter in patients with 
insulin dependant diabetes mellitus 
W . STÖCKER 1 , J . SCHAPER 1 , C H R I S T I N E SCHUHOSE 1 , P . V I E R E G G E 2 , D . K Ö M P F 2 , and P . C . 
SCRIBA 3 
Stiff man syndrome (SMS), a rare disease of the central nervous system, is often associated 
with endocrine disorders, e.g. with insulin-dependent diabetes mellitus ( I D D M ; 1). SMS-
specific autoantibodies were identified. They are directed against gray matter of the brain 
( G M A b ) and can be neutralized with glutamic acid decarboxylase. We observed a 50 year old 
male patient with both, SMS and I D D M . His serum contained G M A b and stained all regions 
of the CNS, in which gray matter was represented. The serum exhibited also islet cell 
antibodies ( ICAb) , but did not react with 22 other extracerebral human tissues, as analyzed by 
indirect immunofluorescence. Surprisingly, sera of 20 patients with I D D M , positive for I C A b , 
reacted in 5 cases with cerebral gray matter, too. In these 5 patients, islet cell as well as gray 
matter fluorescence could be abolished by a preincubation of the sera wi th homogenized 
human gyrus praecentralis. I C A b of the other 15 sera could not be neutralized. O n the other 
hand, 20 IDDM-patients negative for I C A b and 100 healthy blood donors did not exhibit 
GMAbs in the serum. Thus, in some patients wi th I D D M autoimmune reactions may take 
place against cerebral gray matter. The clinical association between I D D M and SMS is 
paralleled by serological phenomena. Furthermore, in I D D M , I C A b with different antigen 
specifities can be observed. The prevalence of SMS in I D D M should be reevaluated. 
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